Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of ICX-TRC dermal papilla cell therapy in male-pattern baldness
2006-001415-29Phase 2Completed
- Sponsor
- Intercytex Group
- Start
- May 2006
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ICX-TRC in androgenetic alopecia (AGA), sponsored by Intercytex Group. Primary endpoints: Hair growth over time and Safety assessment. Started May 2006; status: completed.
02
Drugs
ICX-TRC
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on 2006-001415-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001415-29.